中国肺癌杂志2022，Vol.25Issue(6)：1-16,16.DOI:10.3779/j.issn.1009-3419.2022.103.03
培美曲塞加铂类联合或不联合帕博利珠单抗对初治转移性非鳞状NSCLC患者的疗效与安全性分析:KEYNOTE-189研究方案指定的最终分析
Pemetrexed Plus Platinum With or Without Pembrolizumab in Patients With Previously Untreated Metastatic Nonsquamous NSCLC: Protocol-Specified Final Analysis from KEYNOTE-189
D.RODRíGUEZ-ABREU 1S.Y.CHENG 2H.G.BISCHOFF 3N.PELED 4M.RECK 5R.HUI 6E.B.GARON 7M.BOYER 8T.KURATA 9J.YANG 10M.C.PIETANZA 10S.F.POWELL 11F.SOUZA 10M.C.GARASSINO 12周彩存 13M.J.HOCHMAIR 14S.GADGEEL 15E.ESTEBAN 16E. FELIP 17G.SPERANZA 18F.De ANGELIS 19M.DóMINE19
作者信息
- 1. Medical Oncology, Complejo Hospitalario Universitario Insular Materno-Infantil de Gran Canaria, Universidad de Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain
- 2. Sunnybrook Health Sciences Centre,Toronto, Canada
- 3. Thoraxklinik, Heidelberg, Germany
- 4. Department of Oncology, Shaare Zedek Medical Center, Jerusalem, Israel
- 5. Lungen Clinic, Airway Research Center North, German Center for Lung Research, Grosshansdorf, Germany
- 6. Department of Medical Oncology, Westmead Hospital and University of Sydney, Sydney, Australia
- 7. Department of Medicine, David Geffen School of Medicine at UCLA, Los Angeles, USA
- 8. Department of Medical Oncology, Chris O'Brien Lifehouse, Camperdown, Australia
- 9. Department of Thoracic Oncology, Kansai Medical University Hospital, Osaka, Japan
- 10. Merck & Co., Inc., Kenilworth, USA
- 11. Oncology, Sanford Health, Sioux Falls, USA
- 12. Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
- 13. University of Chicago Medicine & Biological Sciences, Knapp Center for Biomedical Discovery, Chicago, USA
- 14. 同济大学附属上海市肺科医院肿瘤科,上海 200433
- 15. Department of Respiratory and Critical Care Medicine, Karl Landsteiner Institute of Lung Research and Pulmonary Oncology, Klinik Floridsdorf, Vienna, Austria
- 16. Thoracic Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, USA
- 17. Department of Medical Oncology, Hospital Universitario Central de Asturias, Oviedo
- 18. Medical Oncology Department, Vall d'Hebron University, Vall d'Hebron Institute of Oncology (VHIO),Barcelona, Spain
- 19. Centre Integré de Cancérologie de la Montérégie, H?pital Charles-Le Moyne, Greenfield Park, Canada
- 折叠
摘要
关键词
帕博利珠单抗/化疗/非鳞状非小细胞肺癌分类
医药卫生引用本文复制引用
D.RODRíGUEZ-ABREU,S.Y.CHENG,H.G.BISCHOFF,N.PELED,M.RECK,R.HUI,E.B.GARON,M.BOYER,T.KURATA,J.YANG,M.C.PIETANZA,S.F.POWELL,F.SOUZA,M.C.GARASSINO,周彩存,M.J.HOCHMAIR,S.GADGEEL,E.ESTEBAN,E. FELIP,G.SPERANZA,F.De ANGELIS,M.DóMINE..培美曲塞加铂类联合或不联合帕博利珠单抗对初治转移性非鳞状NSCLC患者的疗效与安全性分析:KEYNOTE-189研究方案指定的最终分析[J].中国肺癌杂志,2022,25(6):1-16,16.
